| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| Chain A, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain B, HADH2 protein | 6 | 0 | 0 | 6 |
| Chain A, 2-oxoglutarate Oxygenase | 3 | 0 | 0 | 3 |
| RAR-related orphan receptor gamma | 15 | 0 | 0 | 15 |
| GLI family zinc finger 3 | 17 | 0 | 0 | 17 |
| AR protein | 20 | 0 | 0 | 20 |
| aldehyde dehydrogenase 1 family, member A1 | 12 | 0 | 0 | 12 |
| thyroid stimulating hormone receptor | 8 | 0 | 0 | 8 |
| nuclear receptor subfamily 1, group I, member 3 | 12 | 0 | 0 | 12 |
| progesterone receptor | 9 | 0 | 0 | 9 |
| retinoic acid nuclear receptor alpha variant 1 | 18 | 0 | 0 | 18 |
| estrogen-related nuclear receptor alpha | 15 | 0 | 0 | 15 |
| pregnane X nuclear receptor | 15 | 0 | 0 | 15 |
| estrogen nuclear receptor alpha | 24 | 0 | 0 | 24 |
| aryl hydrocarbon receptor | 3 | 0 | 0 | 3 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 9 | 0 | 0 | 9 |
| cytochrome P450 2D6 isoform 1 | 6 | 0 | 0 | 6 |
| cytochrome P450 2C19 precursor | 4 | 0 | 0 | 4 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| chromobox protein homolog 1 | 11 | 0 | 0 | 11 |
| thyroid hormone receptor beta isoform 2 | 16 | 0 | 0 | 16 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 15 | 0 | 0 | 15 |
| dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 0 | 0 | 1 |
| cytochrome P450 3A4 isoform 1 | 9 | 0 | 0 | 9 |
| lethal factor (plasmid) | 4 | 0 | 0 | 4 |
| Gamma-aminobutyric acid receptor subunit pi | 9 | 1 | 0 | 10 |
| Cytochrome P450 1A1 | 0 | 2 | 0 | 2 |
| Cytochrome P450 1A2 | 0 | 6 | 0 | 6 |
| ATP-dependent translocase ABCB1 | 0 | 4 | 1 | 8 |
| Cytochrome P450 3A4 | 0 | 9 | 0 | 9 |
| Cytochrome P450 2D6 | 0 | 4 | 0 | 4 |
| Cytochrome P450 2A6 | 0 | 2 | 1 | 3 |
| Cytochrome P450 2C9 | 0 | 8 | 0 | 8 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 9 | 1 | 0 | 10 |
| Potassium voltage-gated channel subfamily A member 2 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 0 | 1 | 1 |
| Potassium voltage-gated channel subfamily A member 6 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit delta | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 9 | 1 | 0 | 10 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily A member 3 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily A member 5 | 0 | 0 | 1 | 1 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 9 | 1 | 0 | 10 |
| Cytochrome P450 2C19 | 0 | 4 | 0 | 4 |
| Histamine H2 receptor | 4 | 0 | 0 | 4 |
| Potassium voltage-gated channel subfamily C member 1 | 0 | 0 | 1 | 1 |
| Beta-secretase 1 | 0 | 2 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 9 | 1 | 0 | 10 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 9 | 1 | 0 | 10 |
| Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 2 | 2 |
| Cytochrome P450 1B1 | 0 | 1 | 0 | 1 |
| GABA theta subunit | 9 | 1 | 0 | 10 |
| Gamma-aminobutyric acid receptor subunit epsilon | 9 | 1 | 0 | 10 |
| Bile acid receptor | 0 | 0 | 1 | 1 |
| interleukin 8 | 5 | 0 | 0 | 5 |
| TDP1 protein | 18 | 0 | 0 | 18 |
| estrogen receptor 2 (ER beta) | 7 | 0 | 0 | 7 |
| glucocorticoid receptor [Homo sapiens] | 14 | 0 | 0 | 14 |
| IDH1 | 8 | 0 | 0 | 8 |
| euchromatic histone-lysine N-methyltransferase 2 | 9 | 0 | 0 | 9 |
| Bloom syndrome protein isoform 1 | 5 | 0 | 0 | 5 |
| transcriptional regulator ERG isoform 3 | 4 | 0 | 0 | 4 |
| ras-related protein Rab-9A | 2 | 0 | 0 | 2 |
| geminin | 19 | 0 | 0 | 19 |
| survival motor neuron protein isoform d | 6 | 0 | 0 | 6 |
| lamin isoform A-delta10 | 15 | 0 | 0 | 15 |
| ATP-binding cassette sub-family C member 3 | 0 | 22 | 0 | 22 |
| Multidrug resistance-associated protein 4 | 0 | 22 | 0 | 22 |
| Polyphenol oxidase 2 | 0 | 1 | 1 | 2 |
| Voltage-dependent calcium channel gamma-2 subunit | 8 | 0 | 0 | 8 |
| Bile salt export pump | 0 | 26 | 0 | 26 |
| Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
| Cellular tumor antigen p53 | 17 | 0 | 0 | 17 |
| Glutamate receptor 2 | 9 | 0 | 0 | 9 |
| Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 3 | 1 | 4 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 0 | 2 |
| Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 2 | 1 | 4 |
| Purine nucleoside phosphorylase | 0 | 0 | 2 | 2 |
| TAR DNA-binding protein 43 | 6 | 0 | 0 | 6 |
| Canalicular multispecific organic anion transporter 1 | 0 | 22 | 0 | 22 |
| Shiga toxin subunit A | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Chain A, Cruzipain | 3 | 0 | 0 | 3 |
| phosphopantetheinyl transferase | 7 | 0 | 0 | 7 |
| GLS protein | 6 | 0 | 0 | 6 |
| farnesoid X nuclear receptor | 10 | 0 | 0 | 10 |
| peroxisome proliferator-activated receptor delta | 9 | 0 | 0 | 9 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 8 | 0 | 0 | 8 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 6 | 0 | 0 | 6 |
| peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
| Nuclear receptor ROR-gamma | 7 | 0 | 0 | 7 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 7 | 0 | 7 |
| Aurora kinase B | 0 | 2 | 0 | 2 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 2 | 0 | 2 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 6 | 0 | 0 | 6 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 3 | 0 | 0 | 3 |
| Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
| Chain A, Beta-lactamase | 4 | 0 | 0 | 4 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 1 | 0 | 0 | 1 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
| Chain A, Ferritin light chain | 4 | 0 | 0 | 4 |
| Luciferase | 3 | 0 | 0 | 3 |
| endonuclease IV | 5 | 0 | 0 | 5 |
| thioredoxin reductase | 6 | 0 | 0 | 6 |
| RGS12 | 1 | 0 | 0 | 1 |
| ClpP | 2 | 0 | 0 | 2 |
| 15-lipoxygenase, partial | 1 | 0 | 0 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| ATAD5 protein, partial | 2 | 0 | 0 | 2 |
| USP1 protein, partial | 4 | 0 | 0 | 4 |
| Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
| Thrombopoietin | 2 | 0 | 0 | 2 |
| DNA polymerase III, partial | 2 | 0 | 0 | 2 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
| regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
| nonstructural protein 1 | 2 | 0 | 0 | 2 |
| bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
| galactokinase | 1 | 0 | 0 | 1 |
| hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
| peripheral myelin protein 22 isoform 1 | 3 | 0 | 0 | 3 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 1 | 0 | 0 | 1 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| thyroid hormone receptor beta isoform a | 4 | 0 | 0 | 4 |
| glucokinase regulatory protein | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| guanine nucleotide-binding protein G(i) subunit alpha-1 isoform 1 | 1 | 0 | 0 | 1 |
| DNA polymerase beta | 2 | 0 | 0 | 2 |
| flap endonuclease 1 | 3 | 0 | 0 | 3 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
| DNA polymerase eta isoform 1 | 2 | 0 | 0 | 2 |
| DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 1 | 0 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 1 | 0 | 0 | 1 |
| M-phase phosphoprotein 8 | 4 | 0 | 0 | 4 |
| histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
| pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
| Myc proto-oncogene protein | 0 | 1 | 0 | 1 |
| Complement component C9 | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 1 | 0 | 0 | 1 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Glutamate receptor 1 | 1 | 0 | 0 | 1 |
| Glutamate receptor 3 | 1 | 0 | 0 | 1 |
| Glutamate receptor 4 | 1 | 0 | 0 | 1 |
| Cruzipain | 0 | 1 | 0 | 1 |
| DNA-(apurinic or apyrimidinic site) endonuclease | 0 | 1 | 0 | 1 |
| DNA-3-methyladenine glycosylase | 0 | 1 | 0 | 1 |
| Ribonuclease T | 0 | 0 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 2 | 1 | 4 |
| Delta-type opioid receptor | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 1 | 0 | 1 |
| Cystathionine beta-synthase | 0 | 1 | 0 | 1 |
| Alpha-synuclein | 2 | 0 | 0 | 2 |
| Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
| DNA repair protein RAD52 homolog | 0 | 1 | 0 | 1 |
| Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
| Cell death-related nuclease 4 | 0 | 0 | 0 | 1 |
| Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
| 60 kDa chaperonin | 0 | 3 | 0 | 3 |
| 10 kDa chaperonin | 0 | 3 | 0 | 3 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 2 | 0 | 2 |
| DNA polymerase iota | 0 | 1 | 0 | 1 |
| DNA polymerase eta | 0 | 1 | 0 | 1 |
| Cysteine protease ATG4B | 0 | 1 | 0 | 1 |
| phosphoglycerate kinase | 1 | 0 | 0 | 1 |
| 2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
| ATP-dependent phosphofructokinase | 3 | 0 | 0 | 3 |
| large T antigen | 0 | 1 | 0 | 1 |
| thyroid stimulating hormone receptor | 6 | 0 | 0 | 6 |
| Thymidine kinase | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
| 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
| Thymidine kinase | 0 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 3 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 2 | 2 |
| glp-1 receptor, partial | 7 | 0 | 0 | 7 |
| Fumarate hydratase | 6 | 0 | 0 | 6 |
| Smad3 | 2 | 0 | 0 | 2 |
| EWS/FLI fusion protein | 13 | 0 | 0 | 13 |
| retinoid X nuclear receptor alpha | 10 | 0 | 0 | 10 |
| G | 6 | 0 | 0 | 6 |
| polyprotein | 6 | 0 | 0 | 6 |
| 67.9K protein | 7 | 0 | 0 | 7 |
| Histone H2A.x | 5 | 0 | 0 | 5 |
| cellular tumor antigen p53 isoform a | 3 | 0 | 0 | 3 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 7 | 0 | 0 | 7 |
| huntingtin isoform 2 | 2 | 0 | 0 | 2 |
| tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
| urokinase-type plasminogen activator precursor | 3 | 0 | 0 | 3 |
| plasminogen precursor | 3 | 0 | 0 | 3 |
| urokinase plasminogen activator surface receptor precursor | 3 | 0 | 0 | 3 |
| nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
| muscleblind-like protein 1 isoform 1 | 1 | 0 | 0 | 1 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| bcl-2-like protein 11 isoform 1 | 0 | 0 | 2 | 2 |
| cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 2 | 0 | 2 |
| Interferon beta | 12 | 0 | 0 | 12 |
| HLA class I histocompatibility antigen, B alpha chain | 6 | 0 | 0 | 6 |
| Integrin beta-3 | 3 | 1 | 0 | 4 |
| Integrin alpha-IIb | 3 | 0 | 0 | 3 |
| Deoxycytidine kinase | 0 | 0 | 0 | 2 |
| Adenosine receptor A3 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 6 | 0 | 0 | 6 |
| ATPase family AAA domain-containing protein 5 | 6 | 0 | 0 | 6 |
| Ataxin-2 | 9 | 0 | 0 | 9 |
| cytochrome P450 2C9, partial | 6 | 0 | 0 | 6 |
| Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
| dopamine D1 receptor | 1 | 0 | 0 | 1 |
| pregnane X receptor | 4 | 0 | 0 | 4 |
| peroxisome proliferator activated receptor gamma | 7 | 0 | 0 | 7 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 6 | 0 | 0 | 6 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| heat shock protein beta-1 | 3 | 0 | 0 | 3 |
| muscarinic acetylcholine receptor M1 | 2 | 0 | 0 | 2 |
| Glucocorticoid receptor | 0 | 6 | 2 | 13 |
| Sex hormone-binding globulin | 0 | 0 | 1 | 1 |
| Glycine receptor subunit alpha-1 | 0 | 6 | 0 | 6 |
| Corticosteroid-binding globulin | 0 | 2 | 0 | 2 |
| Glycine receptor subunit beta | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-2 | 0 | 6 | 0 | 6 |
| Glycine receptor subunit alpha-3 | 0 | 6 | 0 | 6 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 15 | 0 | 0 | 15 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 2 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase mTOR isoform 1 | 3 | 0 | 0 | 3 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 1 | 0 | 1 |
| nuclear receptor coactivator 3 isoform a | 0 | 1 | 0 | 1 |
| Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 0 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
| Cytidine deaminase | 0 | 1 | 0 | 2 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
| Deoxycytidine kinase | 0 | 0 | 0 | 1 |
| PPM1D protein | 4 | 0 | 0 | 4 |
| caspase 7, apoptosis-related cysteine protease | 3 | 0 | 0 | 3 |
| caspase-3 | 3 | 0 | 0 | 3 |
| nuclear receptor subfamily 1, group I, member 2 | 4 | 0 | 0 | 4 |
| Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
| Kinesin-like protein KIF11 | 0 | 1 | 0 | 1 |
| Spike glycoprotein | 6 | 1 | 3 | 10 |
| Nucleotide-binding oligomerization domain-containing protein 2 | 0 | 2 | 0 | 2 |
| Sphingosine 1-phosphate receptor 1 | 0 | 0 | 1 | 1 |
| RCG53912, isoform CRA_a | 0 | 0 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 0 | 0 | 1 |
| Sphingosine kinase 2 | 0 | 1 | 0 | 2 |
| Sphingosine kinase 1 | 0 | 1 | 0 | 2 |
| acetylcholinesterase | 4 | 0 | 0 | 4 |
| apical membrane antigen 1, AMA1 | 3 | 0 | 0 | 3 |
| cytochrome P450 2D6 | 5 | 0 | 0 | 5 |
| unnamed protein product | 0 | 1 | 0 | 1 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 3 | 3 | 0 | 0 | 3 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Beta-lactamase | 0 | 1 | 0 | 1 |
| Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 2 | 0 | 2 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| ATP-dependent translocase ABCB1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 2 | 3 |
| Aromatase | 0 | 2 | 0 | 2 |
| Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
| Cytochrome P450 11B2, mitochondrial | 0 | 2 | 0 | 2 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Cytochrome P450 144 | 0 | 0 | 2 | 2 |
| Steroid C26-monooxygenase | 0 | 0 | 2 | 2 |
| Steroid C26-monooxygenase | 0 | 0 | 2 | 2 |
| Mycocyclosin synthase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Lanosterol 14-alpha demethylase | 0 | 1 | 1 | 2 |
| Sterol 14-alpha demethylase | 0 | 0 | 2 | 2 |
| Sterol 14-alpha demethylase | 0 | 2 | 2 | 4 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 2 | 2 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 1 |
| likely tRNA 2'-phosphotransferase | 0 | 1 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| heat shock protein 90 | 0 | 0 | 1 | 1 |
| calcineurin A1, putative | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase PLK1 | 1 | 0 | 0 | 1 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| NFKB1 protein, partial | 1 | 0 | 0 | 1 |
| arylsulfatase A | 5 | 0 | 0 | 5 |
| Solute carrier family 22 member 1 | 0 | 4 | 0 | 6 |
| POU domain, class 2, transcription factor 2 | 0 | 0 | 0 | 1 |
| Transitional endoplasmic reticulum ATPase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 3 | 0 | 1 | 0 | 2 |
| Mu-type opioid receptor | 0 | 3 | 1 | 4 |
| Delta-type opioid receptor | 0 | 5 | 0 | 5 |
| Kappa-type opioid receptor | 0 | 3 | 1 | 4 |
| hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
| GALC protein | 2 | 0 | 0 | 2 |
| activating transcription factor 6 | 4 | 0 | 0 | 4 |
| Cereblon isoform 4 | 0 | 3 | 0 | 3 |
| Bromodomain-containing protein 4 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 2 |
| Breakpoint cluster region protein | 0 | 0 | 0 | 1 |
| DNA-binding protein Ikaros | 0 | 0 | 1 | 4 |
| DNA damage-binding protein 1 | 0 | 2 | 1 | 3 |
| Protein cereblon | 0 | 4 | 2 | 9 |
| Zinc finger protein Aiolos | 0 | 0 | 1 | 1 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 5 | 0 | 1 | 2 | 4 |
| C-C chemokine receptor type 5 | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 5 | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| mitogen-activated protein kinase 1 | 2 | 0 | 0 | 2 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A13 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
| Alpha-2A adrenergic receptor | 0 | 8 | 0 | 8 |
| D(2) dopamine receptor | 0 | 5 | 0 | 5 |
| 5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
| Alpha-1B adrenergic receptor | 0 | 4 | 0 | 4 |
| Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
| Alpha-2C adrenergic receptor | 0 | 4 | 0 | 4 |
| D | 0 | 1 | 0 | 1 |
| D(4) dopamine receptor | 0 | 3 | 0 | 3 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 7 | 0 | 7 |
| 5-hydroxytryptamine receptor 2C | 0 | 7 | 0 | 7 |
| Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Type-2 angiotensin II receptor | 0 | 1 | 0 | 1 |
| Histamine H1 receptor | 0 | 3 | 0 | 3 |
| D(3) dopamine receptor | 0 | 7 | 0 | 7 |
| Alpha-1A adrenergic receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| D(2) dopamine receptor | 0 | 1 | 0 | 1 |
| Transporter | 0 | 2 | 0 | 2 |
| STE24 | 0 | 0 | 0 | 1 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
| CAAX prenyl protease | 0 | 0 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 5 | 5 |
| Trypsin | 0 | 0 | 0 | 1 |
| Albumin | 0 | 0 | 1 | 1 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA gyrase subunit B | 0 | 1 | 0 | 2 |
| DNA gyrase subunit A | 0 | 1 | 0 | 2 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| NPC intracellular cholesterol transporter 1 precursor | 2 | 0 | 0 | 2 |
| Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
| Tubulin alpha-1A chain | 0 | 0 | 1 | 2 |
| Tubulin beta chain | 0 | 0 | 1 | 1 |
| Tubulin beta-4A chain | 0 | 1 | 1 | 3 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
| Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
| Integrin alpha-V | 0 | 1 | 0 | 1 |
| Tubulin beta chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-3C chain | 0 | 1 | 1 | 3 |
| Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 1 | 0 | 1 |
| Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 2 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
| Substance-K receptor | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
| Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
| Melanocortin receptor 5 | 0 | 4 | 0 | 4 |
| UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
| Tubulin alpha-1B chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-4A chain | 0 | 1 | 1 | 3 |
| Tubulin beta-4B chain | 0 | 1 | 1 | 3 |
| Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Mer | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 2 | 1 | 4 |
| Tubulin beta-2A chain | 0 | 1 | 1 | 3 |
| Beta-tubulin | 0 | 1 | 0 | 1 |
| Tubulin beta-8 chain | 0 | 1 | 1 | 3 |
| Tubulin beta-2B chain | 0 | 0 | 1 | 3 |
| Tubulin alpha-3E chain | 0 | 1 | 1 | 3 |
| Tubulin alpha-1A chain | 0 | 1 | 1 | 3 |
| Similar to alpha-tubulin isoform 1 | 0 | 0 | 1 | 3 |
| Similar to alpha-tubulin isoform 1 | 0 | 0 | 0 | 2 |
| Tubulin alpha-1C chain | 0 | 1 | 1 | 3 |
| Tubulin beta-6 chain | 0 | 1 | 1 | 3 |
| Tubulin beta-2B chain | 0 | 1 | 1 | 3 |
| Tubulin beta-1 chain | 0 | 1 | 1 | 3 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S6 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S7 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L15 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L10 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L11 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L7/L12 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L19 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L1 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L20 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L27 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L28 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L29 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L31 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L31 type B | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L32 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L33 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L34 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L35 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L36 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S10 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S11 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S12 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S13 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S16 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S18 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S19 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S20 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S2 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S3 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S4 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S5 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S8 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S9 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L13 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L14 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L16 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L23 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S15 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L17 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L21 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L30 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L6 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S14 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S17 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S1 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L18 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L2 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L3 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L24 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L4 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L22 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L5 | 0 | 2 | 0 | 2 |
| 30S ribosomal protein S21 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L25 | 0 | 2 | 0 | 2 |
| 50S ribosomal protein L36 2 | 0 | 2 | 0 | 2 |
| Protein arginine N-methyltransferase 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 6 | 0 | 6 |
| Protein tyrosine phosphatase type IVA 3 | 0 | 1 | 0 | 1 |
| Coagulation factor X | 0 | 1 | 0 | 1 |
| Plasminogen | 0 | 1 | 0 | 1 |
| Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
| Protein S100-B | 0 | 1 | 1 | 2 |
| Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
| Protein S100-B | 0 | 0 | 1 | 1 |
| Trypsin-1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 6 | 0 | 6 |
| Acrosin | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M4 | 0 | 6 | 0 | 6 |
| Muscarinic acetylcholine receptor M5 | 0 | 6 | 0 | 6 |
| Angiotensin-converting enzyme | 0 | 4 | 0 | 4 |
| Amiloride-sensitive amine oxidase [copper-containing] | 0 | 1 | 0 | 1 |
| Diamine acetyltransferase 1 | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 6 | 0 | 6 |
| Sodium-dependent dopamine transporter | 0 | 4 | 0 | 4 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
| Protein tyrosine phosphatase type IVA 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 4 | 0 | 4 |
| Protein tyrosine phosphatase type IVA 1 | 0 | 1 | 0 | 1 |
| Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Lck | 0 | 1 | 0 | 2 |
| Growth factor receptor-bound protein 2 | 0 | 0 | 0 | 1 |
| Tyrosine-protein phosphatase non-receptor type 11 | 0 | 0 | 0 | 1 |
| Sterol 14-alpha-demethylase | 0 | 0 | 1 | 1 |
| SMAD family member 2 | 3 | 0 | 0 | 3 |
| SMAD family member 3 | 3 | 0 | 0 | 3 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| 14-alpha sterol demethylase | 0 | 0 | 1 | 1 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 4 | 1 | 6 |
| Progesterone receptor | 0 | 3 | 0 | 4 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Androgen receptor | 0 | 2 | 0 | 2 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Androgen receptor | 0 | 3 | 0 | 3 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 4 | 1 | 5 |
| thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
| glucocerebrosidase | 3 | 0 | 0 | 3 |
| Snq2p | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 0 | 1 | 3 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
| D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
| Transmembrane protease serine 2 | 0 | 1 | 3 | 4 |
| Major prion protein | 0 | 0 | 1 | 1 |
| Procathepsin L | 0 | 1 | 3 | 4 |
| Replicase polyprotein 1a | 0 | 1 | 3 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
| Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
| Calmodulin-1 | 0 | 1 | 0 | 1 |
| Replicase polyprotein 1ab | 0 | 1 | 3 | 4 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1A | 0 | 4 | 0 | 4 |
| Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
| D(1A) dopamine receptor | 0 | 4 | 0 | 4 |
| Histamine H2 receptor | 0 | 4 | 0 | 4 |
| Alpha-1D adrenergic receptor | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 1B | 0 | 4 | 0 | 4 |
| Trypanothione reductase | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 4 | 0 | 4 |
| Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
| 5-hydroxytryptamine receptor 2B | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 6 | 0 | 4 | 0 | 4 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Calmodulin | 0 | 0 | 1 | 1 |
| Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 4 | 0 | 4 |
| Angiotensin-converting enzyme 2 | 0 | 1 | 3 | 4 |
| Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
| dual specificity protein phosphatase 3 | 0 | 1 | 0 | 1 |
| low molecular weight phosphotyrosine protein phosphatase isoform c | 0 | 1 | 0 | 1 |
| tyrosine-protein phosphatase non-receptor type 22 isoform 1 | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Estrogen receptor | 0 | 0 | 3 | 4 |
| Beta-hexosaminidase subunit alpha | 0 | 1 | 0 | 2 |
| Beta-hexosaminidase subunit beta | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 2 | 1 | 4 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
| Dihydrofolate reductase | 0 | 3 | 0 | 3 |
| Substance-K receptor | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| Low molecular weight phosphotyrosine protein phosphatase | 0 | 1 | 0 | 1 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| Pteridine reductase 1 | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 1 | 0 | 1 |
| Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
| Estrogen receptor beta | 0 | 0 | 3 | 4 |
| Bifunctional dihydrofolate reductase-thymidylate synthase | 0 | 2 | 0 | 2 |
| Multidrug and toxin extrusion protein 1 | 0 | 1 | 0 | 1 |
| Dihydrofolate reductase | 0 | 1 | 0 | 1 |
| NS5 | 0 | 0 | 1 | 1 |
| alpha-galactosidase | 2 | 0 | 0 | 2 |
| glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Polymerase basic protein 2 | 0 | 0 | 1 | 1 |
| RNA-directed RNA polymerase catalytic subunit | 0 | 0 | 1 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Adenosine receptor A3 | 0 | 3 | 0 | 3 |
| Adenosylhomocysteinase | 0 | 0 | 0 | 2 |
| Adenosine receptor A1 | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Genome polyprotein | 0 | 0 | 1 | 1 |
| acid sphingomyelinase | 1 | 0 | 0 | 1 |
| C-X-C chemokine receptor type 5 isoform 1 | 0 | 1 | 0 | 1 |
| ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
| C-C chemokine receptor type 6 | 0 | 1 | 0 | 1 |
| apelin receptor | 0 | 1 | 0 | 1 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| Endoglycoceramidase II | 0 | 0 | 0 | 1 |
| Protein kinase C alpha type | 0 | 2 | 0 | 2 |
| Protein kinase C delta type | 0 | 2 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 2 |
| Protein kinase C zeta type | 0 | 2 | 0 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 0 | 2 |
| Protein kinase C beta type | 0 | 2 | 0 | 2 |
| Protein kinase C eta type | 0 | 2 | 0 | 2 |
| Protein kinase C theta type | 0 | 2 | 0 | 2 |
| Aurora kinase A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 6 | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecD | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecB | 0 | 1 | 0 | 1 |
| exodeoxyribonuclease V subunit RecC | 0 | 1 | 0 | 1 |
| ATP-dependent 6-phosphofructokinase | 0 | 1 | 0 | 1 |
| Dihydropteroate synthase | 0 | 1 | 0 | 1 |
| Endothelin-1 receptor | 0 | 1 | 0 | 1 |
| Protease | 0 | 1 | 1 | 2 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
| thyrotropin-releasing hormone receptor | 1 | 0 | 0 | 1 |
| Caspase-7 | 1 | 0 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 1 |
| caspase-3 | 1 | 0 | 0 | 1 |
| Serine/threonine-protein kinase D3 | 0 | 1 | 0 | 1 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Protein kinase C gamma type | 0 | 1 | 0 | 1 |
| Protein kinase C beta type | 0 | 1 | 0 | 1 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| Protein kinase C alpha type | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| Thromboxane-A synthase | 0 | 1 | 0 | 1 |
| Protein kinase C eta type | 0 | 1 | 0 | 1 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Protein kinase C iota type | 0 | 1 | 0 | 1 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Estrogen-related receptor gamma | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Protein kinase C epsilon type | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 1 | 0 | 1 |
| Protein kinase C zeta type | 0 | 1 | 0 | 1 |
| Protein kinase C delta type | 0 | 1 | 0 | 1 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 1 | 3 |
| Serine/threonine-protein kinase D1 | 0 | 1 | 0 | 1 |
| Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 1 | 0 | 1 |
| twin arginine protein translocation system - TatA protein | 0 | 0 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |